Host CD73 impairs anti-tumor immunity




Salmi M, Jalkanen S

PublisherLANDES BIOSCIENCE

2012

OncoImmunology

ONCOIMMUNOLOGY

ONCOIMMUNOLOGY

2

1

2

247

248

2

2162-4011

DOIhttps://doi.org/10.4161/onci.1.2.18310



The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on leukocytes and endothelial cells is thus detrimental for the anti-tumor immunity.



Last updated on 2024-26-11 at 21:45